13F

DERM JOURNEY MEDICAL CORP

2026Q1 · CUSIP 48115J109 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
70
Δ holders QoQ
-6
Breadth percentile
Top 80%
Whale holders
43
Δ whales
+1
Inst. holding value
$56M
New positions
12
Closed positions
18
Price momentum (1Q)
Put / Call
1/0

Breadth history (34 quarters)

2022Q1: Δ+0 · h=15 2022Q2: Δ-1 · h=14 2022Q3: Δ+7 · h=21 2022Q4: Δ-2 · h=19 2023Q1: Δ-1 · h=18 2023Q2: Δ+3 · h=21 2023Q3: Δ+1 · h=22 2023Q4: Δ+15 · h=37 2024Q1: Δ-3 · h=34 2024Q2: Δ+2 · h=36 2024Q3: Δ+2 · h=38 2024Q4: Δ+0 · h=38 2025Q1: Δ+1 · h=39 2025Q2: Δ+17 · h=56 2025Q3: Δ+11 · h=67 2025Q4: Δ+9 · h=76 2026Q1: Δ-6 · h=70 2022Q1: holders=15 2022Q2: holders=14 2022Q3: holders=21 2022Q4: holders=19 2023Q1: holders=18 2023Q2: holders=21 2023Q3: holders=22 2023Q4: holders=37 2024Q1: holders=34 2024Q2: holders=36 2024Q3: holders=38 2024Q4: holders=38 2025Q1: holders=39 2025Q2: holders=56 2025Q3: holders=67 2025Q4: holders=76 2026Q1: holders=70 -17 -8.5 +0 +8.5 +17 124680 22Q122Q323Q123Q324Q124Q325Q125Q326Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 1 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q2 Top 18%

Options Sentiment

Put holders
1
QoQ: +1
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-0.37
EPS YoY
Revenue (TTM)
Revenue YoY
Quarterly Revenue & EPS (4Y)
2022-06-30: EPS -0.43 2022-09-30: EPS -0.57 2022-12-31: EPS -0.61 2023-03-31: EPS -0.57 2023-06-30: EPS -0.46 2023-09-30: EPS 0.80 2023-12-31: EPS 0.02 2024-03-31: EPS -0.53 2024-06-30: EPS -0.17 2024-09-30: EPS -0.12 2024-12-31: EPS 0.10 2025-03-31: EPS -0.18 2025-06-30: EPS -0.16 2025-09-30: EPS -0.09 2025-12-31: EPS -0.04 2026-03-31: EPS -0.08 -0.67 0.10 0.88 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 37 2024-06-30: PE 36.9 33 36 39 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)